Rafferty Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
|
|||||
|
2025
Q1 | $2.11M | Sell |
|
|||||
|
2024
Q4 | $2.36M | Buy |
|
|||||
|
2024
Q3 | $3.3M | Sell |
|
|||||
|
2024
Q2 | $3.65M | Sell |
|
|||||
|
2024
Q1 | $8.88M | Sell |
|
|||||
|
2023
Q4 | $8.72M | Buy |
|
|||||
|
2023
Q3 | $4.13M | Sell |
|
|||||
|
2023
Q2 | $7.02M | Buy |
|
|||||
|
2023
Q1 | $5.97M | Buy |
|
|||||
|
2022
Q4 | $6.74M | Buy |
|
|||||
|
2022
Q3 | $3.52M | Buy |
|
|||||
|
2022
Q2 | $1.5M | Sell |
|
|||||
|
2022
Q1 | $2.27M | Sell |
|
|||||
|
2021
Q4 | $3.46M | Buy |
|
|||||
|
2021
Q3 | $1.41M | Sell |
|
|||||
|
2021
Q2 | $2.37M | Sell |
|
|||||
|
2021
Q1 | $3.25M | Buy |
|
|||||
|
2020
Q4 | $396K | Sell |
|
|||||
|
2020
Q3 | $390K | Buy |
|